Neurocrine Bioscienc (NBIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NBIX | ZTS | TAK | UTHR | JAZZ |
| Company | Neurocrine Bioscienc | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | United Therapeutic | Jazz Pharma Plc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 132.65 | 151.50 | 13.18 | 237.47 | 109.27 |
| High | 133.65 | 151.54 | 13.26 | 238.34 | 111.35 |
| Low | 130.13 | 145.80 | 13.17 | 234.86 | 108.88 |
| Last | 132.00 | 146.50 | 13.24 | 237.93 | 109.94 |
| Change | -0.54 | -6.61 | +0.08 | +1.00 | +0.67 |
| % Change | -0.41% | -4.32% | +0.61% | +0.42% | +0.61% |
| Volume | 556,300 | 6,228,841 | 1,316,677 | 616,000 | 756,600 |
| 20-Day Average Volume | 761,990 | 3,985,875 | 1,828,205 | 535,370 | 611,645 |
| Previous Close | 132.54 | 153.11 | 13.16 | 236.93 | 109.27 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 137.07 | 161.48 | 13.63 | 235.86 | 115.00 |
| 20-Day Raw Stochastic | 12.23% | 2.74% | 9.63% | 55.86% | 17.87% |
| 20-Day Relative Strength | 42.24% | 27.37% | 35.12% | 54.14% | 37.53% |
| Weighted Alpha | +27.86 | -23.88 | -21.69 | +5.47 | -25.15 |
| Today's Opinion | 40% Buy | 88% Sell | 100% Sell | 80% Buy | 100% Sell |
| Previous Opinion | 40% Buy | 88% Sell | 100% Sell | 88% Buy | 100% Sell |
| Last Month's Opinion | 88% Buy | 8% Sell | 48% Sell | 40% Buy | 48% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.98% since 04/12/24 | -2.32% since 04/12/24 | -0.97% since 04/12/24 | +2.30% since 04/12/24 | -0.58% since 04/12/24 |
| Low | 130.13 on 04/19/24 | 145.80 on 04/19/24 | 13.11 on 04/17/24 | 230.39 on 04/16/24 | 106.61 on 04/17/24 |
| High | 137.00 on 04/15/24 | 155.00 on 04/15/24 | 13.35 on 04/15/24 | 240.74 on 04/18/24 | 112.27 on 04/15/24 |
| 1-Month | |||||
| %Chg | -6.30% since 03/19/24 | -15.30% since 03/19/24 | -8.12% since 03/19/24 | -0.61% since 03/19/24 | -12.05% since 03/19/24 |
| Low | 130.13 on 04/19/24 | 145.80 on 04/19/24 | 13.11 on 04/17/24 | 221.53 on 04/01/24 | 106.61 on 04/17/24 |
| High | 148.37 on 03/21/24 | 174.33 on 03/21/24 | 14.55 on 03/20/24 | 250.89 on 03/26/24 | 125.95 on 03/21/24 |
| 3-Month | |||||
| %Chg | -3.91% since 01/19/24 | -22.23% since 01/19/24 | -9.99% since 01/19/24 | +9.22% since 01/19/24 | -5.66% since 01/19/24 |
| Low | 128.00 on 02/07/24 | 145.80 on 04/19/24 | 13.11 on 04/17/24 | 208.62 on 02/08/24 | 106.61 on 04/17/24 |
| High | 148.37 on 03/21/24 | 200.53 on 02/29/24 | 14.88 on 02/27/24 | 250.89 on 03/26/24 | 134.17 on 02/26/24 |
| 6-Month | |||||
| %Chg | +18.78% since 10/19/23 | -12.82% since 10/19/23 | -8.88% since 10/19/23 | +5.36% since 10/19/23 | -16.73% since 10/19/23 |
| Low | 103.63 on 11/10/23 | 145.80 on 04/19/24 | 13.11 on 04/17/24 | 208.62 on 02/08/24 | 106.61 on 04/17/24 |
| High | 148.37 on 03/21/24 | 201.92 on 12/14/23 | 15.07 on 01/12/24 | 258.31 on 12/14/23 | 137.38 on 10/20/23 |
| Key Statistics | |||||
| Market Capitalization, $K | 13,188,658 | 70,026,240 | 41,649,004 | 11,149,686 | 6,884,010 |
| Shares Outstanding, K | 99,507 | 457,359 | 3,164,818 | 47,059 | 63,000 |
| Annual Sales | 1,887,100,000 | 8,544,000,000 | 29,803,340,000 | 2,327,500,000 | 3,834,200,000 |
| Annual Net Income | 249,700,000 | 2,344,000,000 | 2,345,930,000 | 984,800,000 | 414,830,000 |
| Last Quarter Sales | 515,200,000 | 2,213,000,000 | 7,556,070,000 | 614,700,000 | 1,011,940,000 |
| Last Quarter Net Income | 147,700,000 | 525,000,000 | 718,900,000 | 217,100,000 | 94,150,000 |
| 60-Month Beta | 0.25 | 0.85 | 0.53 | 0.52 | 0.59 |
| Per-Share Information | |||||
| Most Recent Earnings | 1.44 on 02/07/24 | 1.24 on 02/13/24 | 0.51 on 02/01/24 | 4.36 on 02/21/24 | 5.02 on 02/28/24 |
| Latest Earnings Date | 05/01/24 | 05/02/24 | 05/09/24 | 05/01/24 | 05/08/24 |
| Most Recent Dividend | N/A | 0.432 on 04/18/24 | 0.261 on 09/28/23 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 04/18/24 | 09/28/23 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 55.05 | 28.56 | 6.74 | 11.86 | 6.84 |